Third Pole (also known as Third Pole Therapeutics) is a company that develops cardiopulmonary therapies. It offers inhaled Nitric Oxide (NO) system, a tool that relaxes the blood vessels in the lungs without causing a drop in systemic blood pressure. The company operates in the areas of interstitial lung and chronic obstructive pulmonary disease, hypoxic respiratory failure, pulmonary hypertension, cystic fibrosis, etc.